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ABSTRACT
The objectives of the study were to calculate the 
standardised mortality rates (SMRs) for COVID-19 in 
European Union/European Economic Area countries plus 
the UK and Switzerland and to evaluate the correlation 
between SMRs and selected indicators in the first versus 
the subsequent waves until 23 June 2021. We used 
indirect standardisation (using Italy as the reference) to 
compute SMRs and considered 16 indicators of health and 
social well- being, health system capacity and COVID-19 
response. The highest SMRs were in Belgium, the UK and 
Spain in the first wave (1.20–1.84) and in Hungary, Czechia 
and Slovakia in the subsequent waves (2.50–2.69). Human 
Development Index (HDI), life expectancy, urbanisation and 
healthcare expenditure had positive correlations with SMR 
in the first wave (rho=0.30–0.46), but negative correlations 
(rho=−0.67 to −0.47) in the subsequent waves. Retail/
recreation mobility and transit mobility were negatively 
correlated with SMR in the first wave, while transit mobility 
was inversely correlated with SMR in the subsequent 
waves. The first wave hit most hard countries with high 
HDI, high life expectancy, high urbanisation, high health 
expenditures and high tourism. This pattern may reflect 
higher early community seeding and circulation of the 
virus. Conversely, in the subsequent waves, this pattern 
was completely inversed: countries with more resources 
and better health status did better than eastern European 
countries. While major SMR differences existed across 
countries in the first wave, these differences largely 
dissipated by 23 June 2021, with few exceptions.
INTRODUCTION
European countries have been highly affected 
by the COVID-19 pandemic. Since the begin-
ning of the pandemic in February 2020 and as 
of the second half of June 2021, SARS- CoV-2 
had been linked to almost 1 million deaths 
in the European Union/European Economic 
Area (EU/EEA), with a crude mortality rate 
(CMR) of around 1.6 per 1000 inhabitants.1 
The pattern of the pandemic has varied 
across countries, but a common feature across 
Europe has been the presence of a first wave 
occurring in the spring of 2020 followed by a 
consistent reduction in the spread of the virus 
in the summer and a resumption of epidemic 
activity in the fall of 2020 with second and/
or third waves.2 Therefore, it is possible to 
identify two major phases of SARS- CoV-2 
spread which here we call for consistency, the 
first and subsequent waves. These two phases 
had a different impact in different European 
countries. In the first phase, indeed, Italy 
was the original epicentre of the pandemic 
in Europe,3 with a subsequent spread in 
several western European countries (mainly 
the UK, Sweden, Spain, France, Belgium, 
Germany), while eastern Europe was less 
affected by the virus. As of fall 2020, in addi-
tion to the re- emerging wave in the western 
European countries, an increase in cases and 
consequently in deaths has been observed in 
eastern Europe (especially Hungary, Czechia 
and Slovakia). A key question, therefore, is 
whether there are factors that have favoured 
the different spread of the virus and the 
related deaths among countries and between 
the first and subsequent waves in the same 
countries.
It is known that mortality from COVID-19 
increases with age and it is higher in patients 
Key questions
What is already known?
 ► Since the onset of the COVID-19 pandemic in early 
2020, several studies have been conducted inves-
tigating pandemic trends in terms of deaths and 
crude mortality rates.
What are the new findings?
 ► It is known that mortality from COVID-19 in-
creases with age and it is higher in patients with 
comorbidities.
What do the new findings imply?
 ► The lack of age- stratified data makes comparison 
across countries difficult. Therefore, evidence on the 
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with comorbidities.4–6 Other factors, however, may have 
influenced the different mortality rates in countries, 
explaining, at least in part, these differences. In addi-
tion to the different COVID-19 responses adopted, 
which include containment measures, mandatory face 
covering, the testing, trace and isolation capabilities, and 
to the pre- existing availability of hospital beds,7 other 
social, demographic and economic factors might explain 
the different mortality rates in Europe.
Therefore, the aim of our study was to compare the 
standardised mortality rates (SMRs) of EU/EEA coun-
tries plus the UK and Switzerland between the first and 
subsequent waves of the pandemic and to evaluate the 
correlation patterns between SMRs and selected indi-
cators including sociodemographic and health status 
variables, availability of healthcare resources and facili-
ties and COVID-19 response in the first versus the subse-
quent waves.
METHODS
Comparison of standardised mortality rate of COVID-19 in 
first versus subsequent waves
We obtained the absolute number of COVID-19 deaths 
in each EU/EEA country plus the UK and Switzerland 
as of 23 June 2021, from the Our World in Data data-
base.8 The UK and Switzerland were included because of 
geographical proximity, similar sociocultural factors and 
data availability.
Given the lack of data on age groups of deaths by 
COVID-19 in many countries, we used indirect stan-
dardisation,9 with Italy as the standard population. We 
calculated the CMR for COVID-19 in Italy for each age 
categories (0–9, 10–19, 20–29, 30–39, 40–49, 50–59, 
60–69, 70–79 and ≥80), and subsequently, we calculated 
the expected deaths in each country and the SMR of each 
country. Specifically, to calculate the expected deaths, 
we multiplied the Italian CMR of each age group by the 
population of that age group of the country under study. 
Total expected deaths are given by the sum of expected 
deaths for each age group. Therefore, the SMR is given 
by the ratio of the observed deaths in the country under 
study by the total expected deaths.
SMRs were calculated overall (as of 23 June 2021, 
corresponding to the last available report of the Italian 
National Institute of Health)10 and separately for the first 
and subsequent waves, with their 95% CI.
Concerning the identification of the two waves, we 
referred to the end of the first wave in Italy using the 
date between the two peaks that had the trough (lowest 
number of deaths) for a 7- day average.2
The end of the first wave, thus, was set at 18 August 
2020.
Finally, in order to assess the impact of potential 
different undercounting/overcounting of COVID-19 
deaths across countries in the overall period (through 
23 June 2021), we compared the 0–69 years age group 
SMR with all ages SMR. Countries may differ on how they 
count deaths for elderly individuals, especially in nursing 
homes and those dying at home, while documentation 
may be more standard in non- elderly people. In partic-
ular, we obtained age- stratified data for 16 countries11–14 
for which we calculated the SMR of the 0–69 years age 
group using Italy as the reference country.
Correlation between SMRs and selected indicators
We considered three groups of indicators in relation to 
the different dimensions of (1) health and social well- 
being (sociodemographic and health status), (2) the 
health system capacity (healthcare resources and facili-
ties) and (3) the COVID-19 response, totaling for 16 indi-
cators. In particular, we obtained data from the Eurostat 
Database, the United Nations Database, the World Bank, 
the European Observatory on Health Systems and Polices, 
the Organisation for Economic Co- operation and Devel-
opment (OECD) and the scientific literature.15–21 Online 
supplemental table S1 reports the definition of each indi-
cator and the data source. Online supplemental tables S2 
and S3 show the data for each indicator.
The first group of indicators includes the Human 
Development Index (HDI), the life expectancy at birth, 
the percentage of people at risk of poverty and social 
exclusion, the healthy life years (HLY), the population 
density and the percentage of urbanisation.
As for the health system capacity, we considered the 
number of hospital beds per 1000 inhabitants and the 
number of intensive care units (ICU) beds per 1000 
inhabitants and the proportion of health expenditure on 
the total gross domestic product.
Finally, we included the average value of the Stringency 
Index (SI) (it is a composite measure based on nine 
indicators including school, workplace and public trans-
port closures, cancellation of public events, restrictions 
on public gatherings, stay- at- home requirements, public 
information campaigns, restrictions on internal move-
ments and international travel controls), the average of 
the variation of mobility (retail and recreation, transit, 
outdoor), the test capacity (total tests done per 1000 
inhabitants and the average of new tests done per 1000 
inhabitants) and the variation of number of tourists, as 
indicators of COVID-19 response. Specifically, for each 
country, we averaged the values of the first and subse-
quent waves (from the beginning of the pandemic to 18 
August 2020 and from 19 August 2020 to 23 June 2021, 
respectively) for SI, mobility variation and test capacity. 
Considering the variation of number of tourists, for each 
country, we calculated this indicator in the early period 
of the first (sum of March and April 2020, adjusted per 
million) and the subsequent waves (sum of August and 
September 2020, adjusted per million).
STATISTICAL ANALYSES
We analysed the correlation between SMRs in the first 
and in the subsequent waves and the correlation between 
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the first and subsequent waves, using the Spearman’s 
rank correlation coefficient with 95% bootstrapping CI. 
We compared the correlations calculated in the first and 
subsequent waves with the test of the difference between 
two independent correlation coefficients.22
As an exploratory analysis, a tree- building technique 
called classification and regression tree (CART) anal-
ysis was applied to select the indicators and cut- offs 
thereof that would best describe groups of countries 
with different SMRs, separately in the first and subse-
quent waves. The indicators included and analysed in 
the regression tree were selected from the group of indi-
cators found to be correlated with SMRs. P values<0.005 
were considered statistically significant.23 All statistical 
analyses were performed using Stata software, V.16 
(StataCorp LP, College Station, Texas), and R software, 
V.R.4.0.5 (package rpart).
RESULTS
SMRs in first and subsequent waves
As of 23 June 2021, the SMRs for COVID-19 varied greatly 
across the 31 countries under study (range from 0.07 of 
Iceland to 1.97 of Hungary, table 1). Overall, 11 coun-
tries had an SMR>1, while 19 countries had an overall 
SMR<1 compared with Italy, with the highest SMRs in 
Table 1 Standardised mortality rates (SMRs) for COVID-19 in the European Union/European Economic Area countries plus 
the UK and Switzerland
Country Abbreviation First wave Subsequent waves Variation first/subsequent waves Overall
Austria AT 0.17 0.93 0.76 0.72
Belgium BE 1.80 1.08 −0.72 1.28
Bulgaria BG 0.15 2.07 1.92 1.52
Croatia HR 0.08 1.58 1.50 1.15
Cyprus CY 0.06 0.42 0.36 0.32
Czechia CZ 0.09 2.57 2.48 1.87
Denmark DK 0.23 0.29 0.06 0.27
Estonia EE 0.10 0.73 0.63 0.55
Finland FI 0.12 0.09 −0.03 0.10
France FR 0.89 0.93 0.04 0.92
Germany DE 0.20 0.69 0.49 0.55
Greece EL 0.04 0.79 0.75 0.58
Hungary HU 0.14 2.69 2.55 1.97
Iceland IS 0.08 0.06 −0.02 0.07
Ireland IE 1.06 0.76 −0.30 0.84
Italy* IT 1 1 – 1
Latvia LV 0.03 1.01† 0.98 0.73
Lithuania LT 0.05 1.21 1.16 0.88
Luxemburg LU 0.55 1.21 0.66 1.02†
Malta MT 0.04 0.76 0.72 0.55
Netherlands NL 0.79 0.59 −0.20 0.65
Norway NO 0.12 0.10 −0.02 0.10
Poland PL 0.12 1.82 1.70 1.34
Portugal PT 0.31 1.06 0.75 0.85
Romania RO 0.36 1.37 1.01 1.08
Slovakia SK 0.02 2.50 2.48 1.80
Slovenia SI 0.13 1.67 1.54 1.23
Spain ES 1.20 0.86 −0.34 0.96
Sweden SE 1.18 0.71 −0.47 0.85
Switzerland CH 0.50 0.88 0.38 0.77
United Kingdom UK 1.39 1.16 −0.23 1.22
*Standard population.

















ealth: first published as 10.1136/bm





4 Villani L, et al. BMJ Global Health 2021;6:e006422. doi:10.1136/bmjgh-2021-006422
BMJ Global Health
Hungary, Czechia and Slovakia. According to the waves, 
the highest SMRs were in Belgium, the UK and Spain in 
the first wave (SMRBE=1.80; SMRUK=1.39; SMRES=1.20), 
while in the subsequent waves the highest SMRs were 
from Hungary, Czechia and Slovakia (SMRHU=2.69, 
SMRCZ=2.57; SMRSK=2.50) (table 1). Slovakia, Latvia 
and Malta reported the lowest values in the first 
wave (SMRSK=0.02; SMRLV=0.03; SMRMT=0.04), while 
Iceland, Finland and Norway in the subsequent waves 
(SMRIS=0.06; SMRFI=0.09; SMRNO=0.10). Overall, 12 coun-
tries (Bulgaria, Croatia, Czechia, Hungary, Latvia, Lithu-
ania, Luxemburg, Poland, Portugal, Romania, Slovakia, 
Slovenia) moved from an SMR<1 in the first wave to an 
SMR>1 in the subsequent wave. On the contrary, three 
countries (Ireland, Spain and Sweden) moved from an 
SMR>1 in the first wave to an SMR<1 in the subsequent 
waves (table 1). Countries reporting the highest varia-
tion between the two waves of COVID-19 were Hungary, 
Czechia and Slovakia with low SMRs in the first wave 
and high in the subsequent waves and Belgium, Spain, 
and Sweden in the opposite direction (table 1). Iceland, 
Norway and Finland reported the lowest variation of the 
SMRs between the two waves. Figure 1 reports the rela-
tionship between the SMRs of the first versus the subse-
quent waves. No correlation exists between the two waves 
(rho=−0.06; p=0.75).
Correlates of SMRs in first versus subsequent waves
The correlations between SMRs and the sociodemo-
graphic and health status variables, the healthcare 
resources and facilities and the COVID-19 response are 
summarised in table 2 separately for the first and subse-
quent waves, along with the test of the difference between 
the two coefficients.
Several variables had inverse correlations with SMRs 
in the first versus the subsequent waves. The difference 
in the first versus the subsequent waves was stark and 
reached p<0.005 for the comparison of the two correlation 
coefficients for HDI, life expectancy, urbanisation and 
healthcare expenditure. These variables had positive 
correlations with SMR in the first wave (rho=0.30–0.49), 
but negative correlations with SMR (rho=−0.67 to −0.47) 
in the subsequent waves. Of the variables that reflected 
the response to COVID-19, two mobility variables (retail/
recreation and transit) were negatively correlated 
with SMR in the first wave, that is, countries that were 
more hit had smaller mobility. In the subsequent waves, 
conversely, transit mobility was correlated with SMR, but 
the correlation had been inversed (countries that were 
most hit had higher mobility). Finally, tourism had a posi-
tive correlation with SMR (rho=0.52) in the first wave, but 
no correlation in the subsequent waves.
SMR in the 0–69 years age group
Figure 2 shows the correlation between SMRs in 0–69 
years group versus all ages. There is a strong correlation 
(rho=0.89, p=0.001). However, some countries (Greece, 
Hungary, Poland, Romania, the UK) had worse SMR 
when data were limited to deaths at age 0–69 years as 
compared with their overall SMR picture (online supple-
mental table S4).
CART analysis to describe countries with different SMRs
In the first wave (figure 3), exploratory CART analysis 
produced an optimal tree structure of three terminal 
nodes. The lowest SMR (0.13) was seen in countries 
that paradoxically did not have much reduction in their 
transit mobility and that did not have high health expend-
iture. SMR was modest (0.36) for countries that did not 
have much reduction in their transit mobility and had 
health expenditure>9%. Finally, SMR was highest (1.10) 
in countries that reduced their transit mobility by 35% 
or more (Belgium, France, Ireland, the Netherlands, 
Portugal, Spain and the UK).
Concerning the subsequent waves (figure 4), the pattern 
was inversed. The worse SMR (1.8) was seen in countries 
without high life expectancy (<80 years). Among coun-
tries with life expectancy of 80 years or more, moderate 
SMR (0.99) was seen in those that had HDI<0.95 and 
the lowest SMR (0.46) was seen in nine countries with 
high HDI≥0.94 (Denmark, Finland, Germany, Iceland, 
Ireland, the Netherlands, Norway, Sweden, Switzerland).
DISCUSSION
Our study compared the age standardised COVID-19 
mortality rates of 31 European countries in relation to 
variables reflecting the health and social well- being, 
the health system capacity and the pandemic response. 
Standardisation of mortality rates can help to understand 
better whatever differences exist between countries, as it 
provides an adjusted figure of mortality rates that takes 
into account the different age structures of the compared 
populations.24 We found that SMRs in the first wave 
were not correlated with SMRs in the later phase of the 
pandemic. This means that good performance during 

















































Figure 1 Relationship between the SMRs for COVID-19 
of the first versus the subsequent waves in the EU/EEA 
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or poorly in the subsequent waves. We also found that 
the variables that were most strongly correlated with SMR 
had inverse correlations in the two waves.
The first wave hit most hard countries with high HDI, 
high life expectancy, high urbanisation and high health 
Table 2 Correlation between the standardised mortality rates for COVID-19 in the European Union/European Economic Area 




correlation (95% CI) P value
Subsequent waves 
Spearman’s rho 
correlation (95% CI) P value
P value of the difference 
between first and 
subsequent waves
HDI 0.41 (0.14 to 0.68) 0.02 −0.67 (−0.87 to −0.46) <0.0001 0.000003
Life expectancy at 
birth
0.46 (0.14 to 0.77) 0.01 −0.56 (−0.79 to −0.33) 0.001 0.00002
Poverty and social 
exclusion
0.04 (−0.32 to 0.41) 0.82 0.25 (−0.15 to 0.66) 0.17 0.42
HLY 0.36 (−0.02 to 0.73) 0.05 −0.20 (−0.54 to 0.13) 0.27 0.03
Density 0.33 (−0.03 to 0.68) 0.07 0.17 (−0.24 to 0.57) 0.37 0.52
Urbanisation 0.30 (−0.06 to 0.67) 0.10 −0.51 (−0.77 to −0.24) 0.004 0.0011
Hospital beds* −0.28 (−0.62 to 0.06) 0.13 – – –
ICU beds* −0.16 (−0.48 to 0.15) 0.38 – – –
Healthcare 
expenditure
0.49 (0.22 to 0.76) 0.005 −0.47 (−0.70 to −0.24) 0.008 0.00009
Stringency Index 0.40 (0.09 to 0.70) 0.03 −0.03 (−0.40 to 0.33) 0.85 0.09
Mobility retail and 
recreation
−0.51 (−0.86 to 
−0.15)
0.005 −0.31 (−0.68 to 0.06) 0.10 0.38
Mobility transit −0.66 (−0.90 to 
−0.43)
0.0001 0.50 (0.17 to 0.83) 0.006 0.000001
Mobility outdoor −0.40 (−0.72 to 
−0.07)
0.03 −0.37 (−0.72 to −0.03) 0.05 0.90
Total tests per 1000 0.16 (−0.22 to 0.54) 0.42 −0.24(−0.63 to 0.16) 0.22 0.15
New tests per 1000 0.24 (−0.16 to 0.64) 0.22 −0.25 (−0.69 to 0.20) 0.22 0.94
Tourism 0.52 (0.21 to 0.83) 0.004 0.07 (−0.29 to 0.44) 0.71 0.07
Bold values denote statistical significance at the p ≤ 0.005 level.
*Data were not available for the subsequent waves.








































SMR  overall 0-69  
Figure 2 Relationship between the overall SMRs for 
COVID-19 of the 0-69 group versus all ages group in 16 EU/
EEA countries.
Figure 3 Regression tree diagram in prediction of SMR 
from the socio- demographic and health status, healthcare 
resources and facilities, and the COVID-19 response 
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expenditures. Conversely, in the subsequent waves, these 
countries did better in handling the death toll from 
the epidemic wave. These variables are all correlated 
with each other and, therefore, it is difficult to pinpoint 
which one of them is most important. HDI includes life 
expectancy in its definition, and countries with higher 
HDI also tend to be more urbanised and spend more 
on health. These countries are also likely to have had 
some other features that are not easy to measure but 
which predisposed to a worse outcome during the first 
wave. In particular, these countries are likely to have had 
higher seeding of the virus from abroad and also larger 
dispersion of the virus across their open boundaries and 
highly active economic life before the pandemic became 
recognised and measures were taken. The additional 
strong correlation of SMR with higher tourism volume 
in March and April 2020 is also congruent with higher 
seeding. Conversely, countries with lower HDI, lower 
life expectancy, lower urbanisation and lower tourism 
volume probably faced a lesser challenge, with lower 
seeding burden of SARS- COV-2 and they managed to 
keep the virus as bay despite more limited resources and, 
on average, less prepared healthcare systems.
In the fall of 2020 when a new COVID-19 wave hit, the 
circumstances were inversed. Countries with higher HDI, 
longer life expectancy and spending more on health were 
probably better prepared to handle the new epidemic 
wave. Conversely, other countries did more poorly in this 
phase and some of them also had the worst performance 
overall when the entire pandemic period is considered. 
This is particularly true of eastern European countries 
(eg, Hungary, Czechia, Slovakia and Bulgaria).25 Of note, 
some eastern European countries also have high overall 
population mortality rates (crude death rates) on any 
average year irrespective of COVID-19. For example, the 
overall population mortality for Bulgaria is the highest 
in the world (15.4 per thousand) and most other eastern 
European countries have values exceeding 10 per thou-
sand.26 Moreover, HDI and life expectancy present lower 
values in the countries of eastern Europe (Bulgaria has 
the lowest values among the EU/EEA countries). Simi-
larly, these countries have a lower healthcare expenditure 
and the greater degree of poverty and social exclusion. 
Countries with a more disadvantaged profile may have 
been less able to respond to the crisis. We had no reli-
able information on hospital beds and ICU beds during 
the subsequent waves and data from before the first wave 
would be unwise to use, because many countries urgently 
upgraded their bed capacity in anticipation of escalating 
crisis. Moreover, information on number of beds does 
not suffice to give a good picture of the preparedness and 
functionality of a health system.
Of note, while differences in SMR across countries 
were huge in the first wave (sometimes in the range of 
20–100- fold), differences in SMR across countries for 
the overall pandemic experience shrank a lot by 23 June 
2021. By that time, only five countries managed to retain 
SMR≤0.35 compared with Italy, which was used as the 
reference country. These five countries (Norway, Iceland, 
Finland, Denmark and Cyprus) have managed to contain 
the pandemic extremely effectively. It is difficult to say 
conclusively which the common denominator of their 
success is. All five performed aggressive testing with large 
numbers of tests done despite relatively low levels of 
detected cases. We found no correlation between testing 
and SMR when all European countries were considered, 
but the number of tests done reflects not only the aggres-
siveness of testing but also—mostly—the volume of people 
who seek testing and this is proportional to the epidemic 
burden. Two of these five countries are also islands, and 
like Australia and New Zealand in Oceania,27 28 they had 
the ability to control and close influx of travel in the early 
phase of the pandemic, while this was impossible to do 
as easily for most of the continental European countries. 
Many other explanations of success may be invoked, but 
they should all be cautious since one can easily fall into 
the fallacy of interpreting or overinterpreting sporadic 
data points. Moreover, as of this writing, the pandemic 
is still not over. Therefore, it cannot be excluded that 
further convergence of overall SMRs across different 
countries may happen in the future.
Correlations with mobility indicators are interesting 
to discuss, because they also showed inverse patterns 
between the first and subsequent waves. Reverse causality 
(more epidemic burden leading to more reduction of 
mobility) may be responsible for the paradoxical posi-
tive correlation between more mobility and lower SMR 
in the first wave. The correlation pattern was entirely 
reversed for retail and recreation mobility in the subse-
quent waves. Reduction in mobility is expected to lead 
to reduced exposures and thus decreased burden of the 
epidemic wave. However, not all reduction has the same 
impact on exposures and some reduction in mobility may 
even generate genuinely harmful effects, for example, if 
Figure 4 Regression tree diagram in prediction of SMR 
from the socio- demographic and health status, healthcare 
resources and facilities, and the COVID-19 response 
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it leads to more clustering of people segregated in more 
limited space for longer periods of time. One should be 
very cautious and avoid making inferences on mobility 
effects from ecological data. This same limitation applies 
even more to associations related to aggregate indicators 
of measures, such as the stringency indicator.
Several other limitations should be discussed in this work. 
First, the core of our study used ecological analyses and 
therefore one should be cognizant of the risk of ecological 
fallacy. We advise great caution in trying to make causal 
inferences from ecological variables. The fact that the 
correlations were inversed in the two time periods further 
demonstrates this point. The observed patterns should be 
seen in their totality, as hints for some factors that may or 
may not be possible to measure and which may explain these 
correlations. The same applies to the exploratory CART 
analyses that aimed to describe these patterns rather than 
attribute causality. Second, our analysis makes no claim of 
trying to probe the impact of policy or other measures taken 
to diminish the case load and resulting deaths. There is 
major debate in the literature about the merits of different 
measures29–33 and ecological analyses would be a very weak 
design to study the effects of different non- pharmaceutical 
measures. Third, despite some efforts of standardisation of 
COVID-19 death definition,34 different countries may have 
captured COVID-19 differently and this may have resulted 
both in overcounting and undercounting of deaths.35 36 
For example, countries that ascribe more deaths of nursing 
home residents and of palliative care patients to COVID-19 
would tend to have higher SMR estimates, even though their 
true death burden and lost person- years may not have been 
that high. Differential overcounting and undercounting may 
be more common and more diverse across countries in the 
elderly age groups. Analyses excluding deaths in the elderly 
yielded nevertheless SMRs that correlated substantially with 
those of all- age SMRs, but some countries in eastern Europe, 
Greece and the UK appeared to do much worse when anal-
yses were limited to the non- elderly. Detailed availability of 
age and comorbidity information across all countries would 
allow hopefully performing in the future more granular 
analyses of the relative disease burden of COVID-19.
CONCLUSION
To our knowledge, this is the first study that standard-
ises mortality rates across European countries, allowing 
a better understanding of the differences between coun-
tries. Indeed, the analysis of SMRs shows a different 
evolution of the pandemic, especially comparing eastern 
and western European countries. In particular, the first 
wave hit most hard countries with high HDI, high life 
expectancy, high urbanisation, high health expendi-
ture and high tourism, and this pattern may reflect a 
higher early community seeding and circulation of the 
virus. In the subsequent waves, instead, this pattern was 
completely inversed: countries with more resources and 
better health status did better than eastern European 
countries. Finally, while major SMR differences existed 
across countries in the first wave, these differences largely 
dissipated by 23 June 2021, with few exceptions.
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